Table 1.
Total | |
---|---|
n | 175 |
Age (years) | 66.2 ± 7.7 |
Sex (M/F), n | 139/36 |
Diabetes mellitus, n (%) | 24 (13.7) |
Cardiovascular disease, n (%) | 71 (40.5) |
Drinking, n (%) | 139 (79.9) |
Brinkman index | 606.7 ± 514.2 |
ASA/PS(1/2/3) | 65/109/1 |
% FEV1 | 76.7 ± 7.6 |
% VC | 100.9 ± 12.7 |
Weight loss rate (%) | 3.2 ± 4.6 |
BMI (kg/m2) | 21.1 ± 3.0 |
Alb (g/dL) | 4.1 ± 0.4 |
PNI | 49.3 ± 4.7 |
SGA (A/B/C) | 135/24/16 |
NST intervention, n (%) | 17 (9.7) |
NAC (FP/DCF), n | 122/53 |
Location (Ut/Mt/Lt), n | 36/87/52 |
cStage (II/III), n | 64/111 |
Side effect of chemotherapy | |
Fatigue, n (%) | 14 (8.0) |
Appetite loss, n (%) | 17 (9.7) |
Febrile neutropenia, n (%) | 91 (51.9) |
M: male; F: female; ASA-PS:American Society of Anesthesiologists Physical Status; FEV1.0: Forced Experiratory Volume in one second; VC: Vital Capacity; BMI: Body Mass Index; Alb: Albumin; PNI: Prognostic Nutritional Index; SGA: Subjective Global Assessment; NST: Nutritional Support Team; NAC: Neoadjuvant Chemotherapy.